ORBIMED ADVISORS LLC
Q2 2025 13F Holdings
- Locationnew york, NY
- Num holdings
103
- Value ($000)
$4,004,111
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001055951
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SINOVAC BIOTECH LTD | SHS | P8696W104 | $334.00M | 8 % | 2,718,735 | ||
BSX BOSTON SCIENTIFIC CORP | COM | 101137107 | $302.17M | 8 % | 2,813,200 | ||
LLY ELI LILLY & CO | COM | 532457108 | $263.17M | 7 % | 337,600 | ||
EWTX EDGEWISE THERAPEUTICS INC | COM | 28036F105 | $203.45M | 5 % | 15,518,492 | ||
ELVN ENLIVEN THERAPEUTICS INC | COM | 29337E102 | $159.67M | 4 % | 7,959,538 | ||
ISRG INTUITIVE SURGICAL INC | COM NEW | 46120E602 | $158.13M | 4 % | 291,000 | ||
ARS PHARMACEUTICALS INC | COM | 82835W108 | $144.63M | 4 % | 8,288,510 | ||
SYK STRYKER CORPORATION | COM | 863667101 | $142.11M | 4 % | 359,200 | ||
EW EDWARDS LIFESCIENCES CORP | COM | 28176E108 | $133.58M | 3 % | 1,708,000 | ||
ARGX ARGENX SE | SPONSORED ADR | 04016X101 | $114.65M | 3 % | 208,000 |
Rows Per Page
10
- 10
- 50
- 100